The partnership between the UAB Comprehensive Cancer Center (CCC), Tuskegee University (TU), and Morehouse School of Medecine (MSM) presents a unique opportunity for training the pipeline of future cancer research scientists, with emphasis on miority investigators and cancer health disparities research. The overall goal of the Cancer Training Program is to facilitate both faculty and graduate student training and development in the area of cancer research, in order to increase the number of minority investigators involved in cancer research and/or the number of investigators involved in cancer research as it relates to minority populations. The partnership has successfully developed and implemented cancer research training programs for graduate, post-doctoral, and junior faculty level trainees, and in the past five years has impacted the careers of more than 80 graduate students and junior scientists through this training.
The specific aims are to 1) Implement a 12-month Health Disparities Research Training Program (HDRTP), targeting postdoctoral fellows, junior faculty, and transitional faculty (established faculty who wish to pursue a career in cancer research), including the investigators ofthe pilot projects. Three training tracks will include Community-Based Participatory Research (CBPR), Cancer Control and Population Science (CCPS), and Basic Science in Cancer Research (BSCR); 2) Implement a Summer Cancer Research Training Program (SCRTP) targeting graduate students, to introduce them to the cancer research field and provide them with basic knowledge of cancer health disparities and methods to address these disparities; 3) Provide extended training to graduate students who have excelled in the SCRTP, through the implementation of a year-long Cancer Research Fellows Program;and 4) Improve the integration of all levels of training (graduate students, post-doctoral fellows, and faculty) and promote the CTP as a professional development resource through a Web-based Resource Center, Alumni Program, and symposia.

National Institute of Health (NIH)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Morehouse School of Medicine
United States
Zip Code
Samuel, Temesgen; Fadlalla, Khalda; Gales, Dominique N et al. (2014) Variable NF-?B pathway responses in colon cancer cells treated with chemotherapeutic drugs. BMC Cancer 14:599
Battle, Monica; Gillespie, Corey; Quarshie, Alexander et al. (2014) Obesity induced a leptin-Notch signaling axis in breast cancer. Int J Cancer 134:1605-16
Singh, Rajesh; Gupta, Pranav; Kloecker, Goetz H et al. (2014) Expression and clinical significance of CXCR5/CXCL13 in human non?small cell lung carcinoma. Int J Oncol 45:2232-40
Desai, Arpita; Xu, Jingyao; Aysola, Kartik et al. (2014) Epithelial ovarian cancer: An overview. World J Transl Med 3:1-8
Colbert, Laronna S; Wilson, Kaamilah; Kim, Sungjin et al. (2014) NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer 14:249
Smith, Selina A; Blumenthal, Daniel S (2013) Efficacy to effectiveness transition of an Educational Program to Increase Colorectal Cancer Screening (EPICS): study protocol of a cluster randomized controlled trial. Implement Sci 8:86
Coleman Wallace, Debbie A; Baltrus, Peter T; Wallace, Tracey C et al. (2013) Black white disparities in receiving a physician recommendation for colorectal cancer screening and reasons for not undergoing screening. J Health Care Poor Underserved 24:1115-24
Qin, Yunlong; Xu, Jingyao; Aysola, Kartik et al. (2011) Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. J Cell Physiol 226:3355-67
Caplan, Lee; Stout, Charlotte; Blumenthal, Daniel S (2011) Training physicians to do office-based smoking cessation increases adherence to PHS guidelines. J Community Health 36:238-43
Fortson, Wendell S; Kayarthodi, Shubhalaxmi; Fujimura, Yasuo et al. (2011) Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Int J Oncol 39:111-9

Showing the most recent 10 out of 13 publications